AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Company Profile IFRX Quote InflaRx N.V

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

36.11 4.01 Healthcare

CEO

Niels Riedemann

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.